Loading...
•
Dec 31, 2023
CVS Health Q4 2023 Earnings Report
Announced operating results for the fourth quarter and full-year 2023.
Key Takeaways
CVS Health's Q4 2023 total revenues increased to $93.8 billion, up 11.9% compared to prior year. GAAP diluted EPS was $1.58 and Adjusted EPS was $2.12.
Total revenues increased to $93.8 billion, up 11.9% compared to prior year
GAAP diluted EPS of $1.58 and Adjusted EPS of $2.12
Announced CVS CostVantageTM, which evolves our pharmacy reimbursement model and brings greater transparency and simplicity to the system.
Launched CVS HealthspireTM, the new name for the Health Services segment, which includes Caremark, CordavisTM, Oak Street Health, Signify Health and MinuteClinic®.
Revenue by Segment
Forward Guidance
The Company revised its full-year 2024 GAAP diluted EPS guidance to at least $7.06 from at least $7.26 and its full-year 2024 Adjusted EPS guidance to at least $8.30 from at least $8.50. The Company also revised its full-year 2024 cash flow from operations guidance to at least $12.0 billion from at least $12.5 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...